These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27144939)

  • 21. The effects of cortisol and adrenal androgen on bone mass in Asians with and without subclinical hypercortisolism.
    Ahn SH; Kim JH; Cho YY; Suh S; Kim BJ; Hong S; Lee SH; Koh JM; Song KH
    Osteoporos Int; 2019 May; 30(5):1059-1069. PubMed ID: 30719548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up in adrenal incidentalomas: an Italian multicenter study.
    Morelli V; Reimondo G; Giordano R; Della Casa S; Policola C; Palmieri S; Salcuni AS; Dolci A; Mendola M; Arosio M; Ambrosi B; Scillitani A; Ghigo E; Beck-Peccoz P; Terzolo M; Chiodini I
    J Clin Endocrinol Metab; 2014 Mar; 99(3):827-34. PubMed ID: 24423350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
    Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
    Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone loss rate in adrenal incidentalomas: a longitudinal study.
    Chiodini I; Torlontano M; Carnevale V; Guglielmi G; Cammisa M; Trischitta V; Scillitani A
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5337-41. PubMed ID: 11701701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study.
    Di Dalmazi G; Vicennati V; Rinaldi E; Morselli-Labate AM; Giampalma E; Mosconi C; Pagotto U; Pasquali R
    Eur J Endocrinol; 2012 Apr; 166(4):669-77. PubMed ID: 22267278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone involvement in eugonadal male patients with adrenal incidentaloma and subclinical hypercortisolism.
    Chiodini I; Tauchmanovà L; Torlontano M; Battista C; Guglielmi G; Cammisa M; Colao A; Carnevale V; Rossi R; Di Lembo S; Trischitta V; Scillitani A
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5491-4. PubMed ID: 12466342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with vertebral fracture risk in patients with primary hyperparathyroidism.
    Eller-Vainicher C; Battista C; Guarnieri V; Muscarella S; Palmieri S; Salcuni AS; Guglielmi G; Corbetta S; Minisola S; Spada A; Hendy GN; Cole DE; Chiodini I; Scillitani A
    Eur J Endocrinol; 2014 Sep; 171(3):399-406. PubMed ID: 24966175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study.
    Falcetta P; Orsolini F; Benelli E; Agretti P; Vitti P; Di Cosmo C; Tonacchera M
    Endocrine; 2021 Jan; 71(1):178-188. PubMed ID: 32915435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of body composition using dual-energy X-ray absorptiometry in patients with non-functioning adrenal incidentalomas and an intermediate phenotype: Is there an association with metabolic syndrome?
    Moraes AB; Cavalari EMR; de Paula MP; Arruda M; Curi DSC; Leitão RA; de Mendonça LMC; Farias MLF; Madeira M; Vieira Neto L
    J Endocrinol Invest; 2019 Jul; 42(7):797-807. PubMed ID: 30465247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mild autonomous cortisol secretion in adrenal incidentalomas and risk of fragility fractures: a large cross-sectional study.
    Zavatta G; Vicennati V; Altieri P; Tucci L; Colombin G; Coscia K; Mosconi C; Balacchi C; Fanelli F; Malagrinò M; Magagnoli M; Golfieri R; Pagotto U; Di Dalmazi G
    Eur J Endocrinol; 2023 Apr; 188(4):343-352. PubMed ID: 36952249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visceral fat accumulation and postdexamethasone serum cortisol levels in patients with adrenal incidentaloma.
    Debono M; Prema A; Hughes TJ; Bull M; Ross RJ; Newell-Price J
    J Clin Endocrinol Metab; 2013 Jun; 98(6):2383-91. PubMed ID: 23633207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center.
    Patrova J; Kjellman M; Wahrenberg H; Falhammar H
    Endocrine; 2017 Nov; 58(2):267-275. PubMed ID: 28887710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism.
    Chiodini I; Morelli V; Salcuni AS; Eller-Vainicher C; Torlontano M; Coletti F; Iorio L; Cuttitta A; Ambrosio A; Vicentini L; Pellegrini F; Copetti M; Beck-Peccoz P; Arosio M; Ambrosi B; Trischitta V; Scillitani A
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2736-45. PubMed ID: 20375210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures: Results of a Prospective Observational Cohort Study.
    van der Weijden MA; van Denderen JC; Lems WF; Nurmohamed MT; Dijkmans BA; van der Horst-Bruinsma IE
    J Rheumatol; 2016 Apr; 43(4):758-64. PubMed ID: 26879348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism.
    Palmieri S; Morelli V; Polledri E; Fustinoni S; Mercadante R; Olgiati L; Eller Vainicher C; Cairoli E; Zhukouskaya VV; Beck-Peccoz P; Chiodini I
    Eur J Endocrinol; 2013 Mar; 168(3):289-96. PubMed ID: 23211572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcaneus ultrasonometry and dual-energy X-ray absorptiometry for the evaluation of vertebral fracture risk.
    Frediani B; Acciai C; Falsetti P; Baldi F; Filippou G; Siagkri C; Spreafico A; Galeazzi M; Marcolongo R
    Calcif Tissue Int; 2006 Oct; 79(4):223-9. PubMed ID: 16969597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bone mineral density and biological markers of bone repair in patients with adrenal incidentaloma: effect of subclinical hypercortisolism].
    Bardet S; Rohmer V; Boux de Casson F; Coffin C; Ronci N; Sabatier JP; Lecomte P; Audran M; Henry-Amar M; Tabarin A
    Rev Med Interne; 2002 Jun; 23(6):508-17. PubMed ID: 12108175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
    Araujo-Castro M; Hanzu FA; Pascual-Corrales E; García Cano AM; Marchan M; Escobar-Morreale HF; Valderrabano P; Casals G
    Endocrine; 2023 Oct; 82(1):161-170. PubMed ID: 37351760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of urinary free cortisol with bone formation in patients with mild autonomous cortisol secretion.
    Ishida A; Igarashi K; Ruike Y; Ishiwata K; Naito K; Kono S; Deguchi H; Fujimoto M; Shiga A; Suzuki S; Yoshida T; Tanaka T; Tatsuno I; Yokote K; Koide H
    Clin Endocrinol (Oxf); 2021 Apr; 94(4):544-550. PubMed ID: 33296503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cortisol secretion from adrenal adenomas discovered as incidentalomas is responsive to ACTH.
    Olsen H; Olofsson L; Mjöman M
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):335-41. PubMed ID: 23865937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.